Skip to content

Family Psychoeducation for Children With Mood Disorders

Family Psychoeducation: Efficacy in Child Mood Disorders

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00050557
Enrollment
165
Registered
2002-12-16
Start date
2001-07-31
Completion date
2006-12-31
Last updated
2012-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mood Disorders

Brief summary

The purpose of this study is to evaluate the effectiveness of a Multifamily Psychoeducation Group for the families of children with mood disorders.

Detailed description

Mood disorders among youth are a major health concern. Existing mood disorder studies focus on adults, and studies that focus on effective intervention strategies for youth with mood disorders are needed. This 8-session study is an adjunct to ongoing medication management and individual and family psychotherapy for children with mood disorders. In this study, parents learn about mood disorders, their treatments, and how to work effectively with mental health and school systems. Parents also practice problem-solving and communication skills for symptom management. Children learn about mood disorders and their treatments, including basic cognitive-behavioral principles. Children also learn and practice anger management, problem-solving, and communication skills. Patients and their families are randomly assigned to 1 of 2 groups. The first group receives 8 sessions of psychoeducation plus treatment as usual (TAU). The second group is a wait-list control in which participants receive only TAU. Patients and caregivers undergo a variety of interviews, tests, and behavioral observations throughout the study. Anxiety, depression, psychosocial stressors, manic symptoms, and children's experiences with psychotropic medications and with treatment or service providers are assessed. Caregivers, teachers, and family friends undergo interviews and make observations of the patient's level of support, general appearance and behavior, and overall functional capacity. The extent to which caregivers agree on the need for treatment and the extent of caregivers' knowledge of mood disorders is also assessed. Assessments occur at 3, 6, 12, 15, and 18 months after study enrollment. A comprehensive assessment is conducted at study entry and 1 year later.

Interventions

BEHAVIORALMultifamily Psychoeducation Group (MFPG)

MFPG will include 8 weekly 90-minute group therapy sessions.

BEHAVIORALTreatment as usual (TAU)

Participants will receive standard care for mood disorders.

Sponsors

National Institute of Mental Health (NIMH)
CollaboratorNIH
Mary Fristad
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
8 Years to 11 Years
Healthy volunteers
No

Inclusion criteria

* Major depressive disorder, dysthymic disorder, or bipolar disorder (Type I or II) * IQ greater than 70 * At least one parent/caregiver willing to participate in the study * Able to attend six or more of the eight treatment sessions with at least 1 parent

Design outcomes

Primary

MeasureTime frame
Mood Severity IndexMeasured at Months 6 and 12

Secondary

MeasureTime frame
Rage Index (MRS irritability + disruptive-aggressive items)Measured at Months 6 and 12

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 2, 2026